摘要历史上中外医药学交流频繁，外来药物传入我国后均被赋予中药药性，历经效用衍化的过程，可称为“中药化”。本文以印度传入我国的天然药物为研究对象，发现阿育吠陀医学与中医学理论的共性认识是印度天然药物“中药化”的理论基础，印度药物需通过二者医药理论对应关系基础上的中药属性赋予及共性认识外的性效补充2个途径完成“中药化”过程。印度天然药物“中药化”案例可为更多外来新药的“中药化”研究提供理论与实践基础。

abstractsIn history, there were frequent medical exchanges between China and foreign countries. After the introduction of foreign drugs, they are endowed with the properties of Chinese materia medica and undergo a process of utility evolution, which can be called "Chinese materia medica transformation". This article took natural drugs introduced from India as the research object and found that the common understanding between Ayurvedic medicine and TCM theory is the theoretical basis for the Chinese materia medica transformation" of natural drugs in India. Indian drugs need to complete the process of "Chinese materia medica transformation" through two approaches: the attribution of Chinese materia medica attributes based on the corresponding relationship between the two medical theories, and the supplementation of properties and effects beyond the common understanding. The case of "Chinese materia medica transformation" of natural drugs in India can provide a theoretical and practical basis for the research of "Chinese materia medica transformation" of more foreign new drugs.